| Literature DB >> 33294434 |
Xinheng Zhang1,2,3, Qiqi Zhao1,2, Xiaotong Ci1,2, Sheng Chen1,2, Liyi Chen1,2,3, Jiamin Lian1,2,3, Zi Xie1,2,3, Yaqiong Ye4, Huiyuan Lv5, Hongxin Li1,2,3, Wencheng Lin1,2,3, Huanmin Zhang6, Qingmei Xie1,2,3.
Abstract
H9N2 subtype avian influenza virus (H9N2 AIV) is a low pathogenic virus that is widely prevalent all over the world. H9N2 AIV causes immunosuppression in the host and often leads to high rates of mortality due to secondary infection with Escherichia. Due to the drug resistance of bacteria, many antibiotics are not effective in the treatment of secondary bacterial infection. Therefore, the purpose of this study is to find effective nonantibiotic drugs for the treatment of H9N2 AIV infection-induced secondary bacterial infection and inflammation. This study proves, for the first time, that baicalin, a Chinese herbal medicine, can regulate Lactobacillus to replace Escherichia induced by H9N2 AIV, so as to resolve the intestinal flora disorder. In addition, baicalin can effectively prevent intestinal bacterial translocation of SPF chickens' post-H9N2 AIV infection, thus inhibiting secondary bacterial infection. Furthermore, baicalin can effectively treat H9N2 AIV-induced inflammation by inhibiting intestinal structural damage, inhibiting damage to ileal mucus layer construction and tight junctions, improving antioxidant capacity, affecting blood biochemical indexes, and inhibiting the production of inflammatory cytokines. Taken together, these results provide a new theoretical basis for clinical prevention and control of H9N2 AIV infection-induced secondary bacterial infection and inflammation.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33294434 PMCID: PMC7691011 DOI: 10.1155/2020/2524314
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
The design of experimental groups in this study.
| Group | Treatment | Number of chickens |
|---|---|---|
| Mock group | Basal diet | 20 |
| Baicalin group | Basal diet and baicalin | 20 |
| H9N2 virus infection group | Basal diet, challenge at 9 days old (3-fold 106 EID50/0.1 mL) | 20 |
| H9N2 infection and baicalin group | Basal diet and baicalin, challenge at 9 days old (3-fold 106 EID50/0.1 mL) | 20 |
Ingredient composition and nutrient content of the basal diet (%, as-fed basis) [21].
| Ingredient | Proportion (kg) | Nutrient levels | Content |
|---|---|---|---|
| Corn | 59.00 | Metabolic energy/(MJ/kg) | 12.64 |
| 46% soybean | 29.50 | Crude protein | 21.30 |
| Soybean oil IV | 2.80 | Calcium | 0.83 |
| Corn gluten meal | 4.50 | Available phosphorus | 0.34 |
| Calcium hydrogen phosphate | 1.30 | Lysine | 1.15 |
| Limestone | 1.20 | Methionine | 0.47 |
| Sodium chloride | 0.30 | ||
| L-Lysine | 0.25 | ||
| Methionine | 0.15 | ||
| 1Premix | 1.00 | ||
| Total | 100 |
1Premix is provided per kilogram of diet: Mn (MnSO4·H2O) 60 mg; Fe (FeSO4·H2O) 66.5 mg; Zn (ZnSO4·7H2O) 88 mg; Cu (CuSO4·5H2O) 8.8 mg; I (CaI2) 0.7 mg; Se (Na2SeO3) 0.288 mg; VA11 500 IU; VD33 500 IU; VE 30 mg; VK 33 mg; VB1 3.38 mg; VB2 9.00 mg; VB6 8.96 mg; VB12 0.025 mg; choline chloride 800 mg; calcium pantothenate 13 mg; niacin 45 mg; biotin 0.08 mg; folic acid 1.20 mg.
Primers for RT-qPCR detection of intestinal inflammation-related cytokines.
| Gene names | Primers |
|---|---|
|
| F: ATCATACTGAGCCAGATTGTTTCG |
| R: TCTTTCACCTTCTTCACGCCAT | |
|
| F: CAGGAATCGCACCTACACCT |
| R: TCATGTAGCAGCGGTTGTTC | |
|
| F: AGATGGGAAGGGAATGAACC |
| R: TCAGAGCATCAACGCAAAAG | |
|
| F: CCATTCCAGGTGCGTGAACT |
| R: TTTCTTCTCCAGGCGGTACG | |
|
| F: TGCCTGCAGAAGAAGCCTCG |
| R: CTCCGCAGCAGTTTGGTCAT | |
|
| F: CGAGGAGAAATGCCTGACGA |
| R: TGGGATGACCACTTCATCGG | |
|
| F: AGGCTGAGAACGGGAAACTTG |
| R: CACCTGCATCTGCCCATTTG |
Primers for RT-qPCR detection of mucosal barrier-related indexes.
| Gene names | Primers |
|---|---|
|
| F: AATGCTGAGTTCTTGCCTAA |
| R: GTTGCAGTTCATATCCTGGT | |
|
| F: GCCTGAATCAAACCCAGCAA |
| R: TATGCGGCGGTAAGGATGAT | |
|
| F: GAAGGGCTGTGGATGAACTG |
| R: GAGACGATGGTGATCTTGGC | |
|
| F: TGGTCCCCAGGACTCAG |
| R: GGTAGCACAGTTCACTCGG | |
|
| F: AGGCTGAGAACGGGAAACTTG |
| R: CACCTGCATCTGCCCATTTG |
Figure 1The addition of baicalin regulated the ileal microbiota composition caused by H9N2 AIV infection in chickens at 5 dpi and 12 dpi. The ileal microbiota from mock, H9N2 AIV infection, baicalin-fed, and H9N2 AIV infection plus baicalin groups at 5 dpi was analyzed by sequencing using the Illumina HiSeq system. The relative abundances of the (a) bacterial phyla, (b) families, and (c) genera are displayed. (d) A Venn diagram of OTUs (operational taxonomic units) in different groups at 5 dpi is shown. The ileal microbiota from the mock, H9N2 AIV infection, baicalin-fed, and H9N2 AIV infection and baicalin groups at 12 dpi was analyzed by sequencing using the Illumina HiSeq system. The relative abundances of the (e) bacterial phyla and (f) genera are displayed. The cutoff abundance level was set at 0.01%. Data are presented as the mean ± standarddeviation of three independent biological experiments. The differences between groups were analyzed using ANOVA. ∗P < 0.05 and ∗∗P < 0.01.
Isolation of bacteria from lung, liver, and mesentery post-H9N2 AIV infection in SPF chickens.
| Days postinfection | Tissue | Mock | H9N2 | Baicalin-H9N2 | Baicalin |
|---|---|---|---|---|---|
| 5 dpi | Intestinal cavity | +(3/3) | +(3/3) | +(3/3) | +(3/3) |
| Liver | -(3/3) | +(1/3) | -(3/3) | -(3/3) | |
| Lung | -(3/3) | +(2/3) | -(3/3) | -(3/3) | |
| Mesentery | -(3/3) | +(3/3) | -(3/3) | -(3/3) | |
| 12 dpi | Intestinal cavity | +(3/3) | +(3/3) | +(3/3) | +(3/3) |
| Liver | -(3/3) | +(3/3) | -(3/3) | -(3/3) | |
| Lung | -(3/3) | +(3/3) | -(3/3) | -(3/3) | |
| Mesentery | -(3/3) | +(3/3) | -(3/3) | -(3/3) |
+ means isolated bacteria was positive; - means isolated bacteria was negative. Number (front)/number (back): number (front) means the number of positive or negative isolated bacteria; number (back) means the number of total isolated bacteria.
Identification of Neongreen-tagged bacteria in different tissues of different groups after the infected chickens were drenched with labeled bacteria at 12, 24, 36, and 48 hours.
| Neongreen | H9N2-Neongreen | Baicalin-Neongreen | H9N2-baicalin-Neongreen | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 h | 24 h | 36 h | 48 h | 12 h | 24 h | 36 h | 48 h | 12 h | 24 h | 36 h | 48 h | 12 h | 24 h | 36 h | 48 h | |
| Intestinal cavity | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 | +3/3 |
| Mesentery | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | +3/3 | +2/3 | +3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 |
| Lung | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | +1/3 | +2/3 | +3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 |
| Liver | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | +1/3 | +2/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 | -3/3 |
+ means isolated bacteria was positive; - means isolated bacteria was negative. Number (front)/number (back): number (front) means the number of positive or negative isolated bacteria; number (back) means the number of total isolated bacteria.
Figure 2The addition of baicalin effectively prevented translocation of Neongreen-labeled bacteria in SPF chickens' post-H9N2 AIV infection. Isolation of Neongreen-labeled bacteria from the intestinal cavity, mesentery, lungs, and liver was conducted in different groups including Neongreen, H9N2-Neongreen, baicalin-Neongreen, and H9N2-baicalin-Neogreen after the infected chickens were drenched with labeled bacteria at 12, 24, 36, and 48 hours.
Figure 3The addition of baicalin alleviated intestinal histopathological changes in the ileum and cecum caused by H9N2 AIV infection at 5 dpi and 12 dpi. (a) Histological features of the ileal mucosa were compared between the H9N2 AIV infection plus baicalin (H9N2-baicalin) and H9N2 AIV infection groups using hematoxylin and eosin staining at 5 dpi and 12 dpi. Images are provided at a lower magnification (100x) for histological observation and statistics. The (b) villus length (c) and crypt depth of the ileum were measured by Image-Pro Plus 6.0. (d) The spatial distribution of the villus length/crypt depth of the ileum is shown. (e) Histological features of cecum mucosa between the group of feeding baicalin with H9N2 AIV infection (H9N2-baicalin) and H9N2 AIV infection were investigated with hematoxylin and eosin staining at 5 dpi and 12 dpi. Images are provided at a lower magnification (100x) for histological observation and statistics. The (f) villus length and (g) crypt depth of the cecum were measured with the Image-Pro Plus 6.0 software. (h) The spatial distribution of villus length/crypt depth of the cecum is shown. Data are presented as the mean ± standarddeviation of three independent biological experiments. The differences between groups were analyzed using ANOVA. ∗P < 0.05 and ∗∗P < 0.01.
Figure 4The addition of baicalin increased the mRNA expression levels of TFF2, MUC2, ZO-1, and Claudin-3 that were downregulated by H9N2 AIV infection in the ileal epithelial cells, as found by RT-qPCR. (a) The mRNA expression level of TFF2 at 5 dpi and 12 dpi. (b) The mRNA expression level of MUC2 at 5 dpi and 12 dpi. (c) The mRNA expression level of ZO-1 at 5 dpi and 12 dpi. (d) The mRNA expression level of Claudin-3 at 5 dpi and 12 dpi. Data are presented as themean ± standarddeviation of three independent biological experiments. The differences between groups were analyzed using ANOVA. ∗∗P < 0.01.
Figure 5The addition of baicalin improved the antioxidant capacity of SPF chickens' post-H9N2 AIV infection. (a) Baicalin reversed the downregulation of the serum total antioxidant capacity caused by H9N2 AIV infection at 5 dpi and 12 dpi. (b) Baicalin reversed the upregulation of the serum malondialdehyde concentration caused by H9N2 AIV infection at 5 dpi and 12 dpi. (c) Baicalin reversed the downregulation of the serum glutathione peroxidase concentration caused by H9N2 AIV infection at 5 dpi and 12 dpi. (d) Baicalin reversed the downregulation of the serum total superoxide dismutase concentration caused by H9N2 AIV infection at 5 dpi and 12 dpi. Data are presented as the mean ± standarddeviation of three independent biological experiments. The differences between groups were analyzed using ANOVA. ∗P < 0.05 and ∗∗P < 0.01.
Figure 6The beneficial effects of baicalin on the health status of chickens. (a) Baicalin reversed the increase in serum aspartate aminotransferase caused by H9N2 AIV infection at 5 dpi and 12 dpi. (b) Baicalin reversed the increase in serum alanine aminotransferase caused by H9N2 AIV infection at 5 dpi and 12 dpi. (c) Baicalin reversed the increase in serum urea nitrogen caused by H9N2 AIV infection at 5 dpi and 12 dpi. (d) Baicalin reversed the increase in serum total cholesterol caused by H9N2 AIV infection at 5 dpi and 12 dpi. (e) Baicalin reversed the decrease in serum high-density cholesterol caused by H9N2 AIV infection at 5 dpi and 12 dpi. (f) Baicalin reversed the increase in serum low-density cholesterol caused by H9N2 AIV infection at 5 dpi and 12 dpi. Data are presented as the mean ± standarddeviation of three independent biological experiments. The differences between groups were analyzed using ANOVA. ∗P < 0.05 and ∗∗P < 0.01.
Figure 7The addition of baicalin alleviated the inflammatory response of SPF chickens by affecting the mRNA expression of the cytokines IFN-γ, TFN-a, IL-22, IL-17A, IL-6, and IL-1β. (a) The mRNA expression of IFN-γ at 5 dpi and 12 dpi in different groups. (b) The mRNA expression of TFN-a at 5 dpi and 12 dpi in different groups. (c) The mRNA expression of IL-22 at 5 dpi and 12 dpi in different groups. (d) The mRNA expression of IL-17A at 5 dpi and 12 dpi in different groups. (e) The mRNA expression of IL-6 at 5 dpi and 12 dpi in different groups. (f) The mRNA expression of IL-1β at 5 dpi and 12 dpi in different groups. Data are presented as the mean ± standarddeviation of three independent biological experiments. The differences between groups were analyzed using ANOVA. ∗P < 0.05 and ∗∗P < 0.01.